The market for algal astaxanthin may be full of synthetic and yeast-derived forms.
Flamingos, crabs, and other animals get their red color from dining on Haematococcus microalgae. It’s a primary source of the carotenoid astaxanthin, which consumers are increasingly aware of for its antioxidant potential. But as astaxanthin supplements grow in popularity, many human consumers are presumably and unknowingly purchasing adulterated astaxanthin.
Cyanotech Corp. (Kailua-Kona, HI), a supplier of algae-derived astaxanthin, says it recently conducted tests on raw material of astaxanthin and discovered that much of it is inappropriately labeled as containing natural astaxanthin from microalgae. The samples in question actually contain astaxanthin from petrochemicals or genetically-mutated yeast. The former source does not appear to have approval for consumption in any country, and yeast-derived astaxanthin only has limited approval in select countries. While the United States allows the sale of yeast-derived astaxanthin with a recommended daily dosage of 2 mg, the ingredient is not approved for children.
Gerald Cysewski, PhD, chief science officer and founder of Cyanotech, says the adulteration is sliding into the market because it is difficult to distinguish between natural and synthetic astaxanthin in lab tests.
“If you compare algae-based astaxanthin to the synthetic or yeast-based varieties, you find that they have the same chemical formula, but the molecules are shaped completely differently,” says Cysewski, adding that natural astaxanthin is esterified with fatty acids and naturally occurring with other carotenoids, such as lutein and beta-carotene. “Even though they all have the same chemical formula, the three forms of astaxanthin are totally different products.”
Natural astaxanthin is quite challenging to grow, says Cyanotech. In order to satisfy a demand that is currently outrunning supply, there appears to be mislabeled, illegal, and untested astaxanthin on the local market.
Cyanotech markets Hawaiian-grown BioAstin astaxanthin, blended with safflower oil, in dietary supplement gelcaps.
Balchem’s Newest Launch Optifolin⁺® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin⁺, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.